AstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reports
AstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reports Nov 4 (Reuters) - AstraZeneca AZN.L made an about $10 billion offer to acquire rare-disease drugmaker Rhythm Pharmaceuticals RYTM.O, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Leroy Leo)
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)